VIM and neoplasm: The analysis of patient serum, reported in Table 4, revealed the presence of a series of antibodies compatible with PNP or the underlying neoplasm, such as desmogleins 1 and 3, CA 125, vimentin, PSA, Ig γ-paraprotein, PIVKA-II, CA 15-3, and other molecules.